Literature DB >> 9409355

Familial amyotrophic lateral sclerosis. Molecular pathology of a patient with a SOD1 mutation.

C E Shaw1, Z E Enayat, J F Powell, V E Anderson, A Radunovic, S al-Sarraj, P N Leigh.   

Abstract

We report the clinical, genetic, and neuropathologic findings in a patient with rapidly progressive familial amyotrophic lateral sclerosis (ALS). We detected a point mutation at codon 48 of the Cu/Zn superoxide dismutase gene (SOD1) leading to a substitution of histidine by glutamine in the copper-binding domain. The histopathologic features are consistent with those described in rapidly progressive sporadic ALS and do not support claims that sporadic and familial disease are different pathologic entities. Neurofilamentous accumulations, hyaline, and ubiquitinated inclusions were present in the motor cortex, brainstem, and anterior horn cells, but there was no evidence of abnormal SOD1 immunoreactivity. This confirms that the cytoskeletal pathology specific to ALS is secondary to an unknown biochemical disturbance caused by mutant SOD1 molecules and not its toxic accumulation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9409355     DOI: 10.1212/wnl.49.6.1612

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

Review 1.  Progress in the pathogenesis of amyotrophic lateral sclerosis.

Authors:  C E Shaw; A al-Chalabi; N Leigh
Journal:  Curr Neurol Neurosci Rep       Date:  2001-01       Impact factor: 5.081

2.  Two families with familial amyotrophic lateral sclerosis are linked to a novel locus on chromosome 16q.

Authors:  Deborah M Ruddy; Matthew J Parton; Ammar Al-Chalabi; Cathryn M Lewis; Caroline Vance; Bradley N Smith; P Nigel Leigh; John F Powell; Teepu Siddique; Eelco Postumus Meyjes; Frank Baas; Vianney de Jong; Christopher E Shaw
Journal:  Am J Hum Genet       Date:  2003-07-01       Impact factor: 11.025

3.  Interaction of amyotrophic lateral sclerosis (ALS)-related mutant copper-zinc superoxide dismutase with the dynein-dynactin complex contributes to inclusion formation.

Authors:  Anna-Lena Ström; Ping Shi; Fujian Zhang; Jozsef Gal; Renee Kilty; Lawrence J Hayward; Haining Zhu
Journal:  J Biol Chem       Date:  2008-05-30       Impact factor: 5.157

Review 4.  From animal models to human disease: a genetic approach for personalized medicine in ALS.

Authors:  Vincent Picher-Martel; Paul N Valdmanis; Peter V Gould; Jean-Pierre Julien; Nicolas Dupré
Journal:  Acta Neuropathol Commun       Date:  2016-07-11       Impact factor: 7.801

5.  Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of amyotrophic lateral sclerosis.

Authors:  Rachel Tesla; Hamilton Parker Wolf; Pin Xu; Jordan Drawbridge; Sandi Jo Estill; Paula Huntington; Latisha McDaniel; Whitney Knobbe; Aaron Burket; Stephanie Tran; Ruth Starwalt; Lorraine Morlock; Jacinth Naidoo; Noelle S Williams; Joseph M Ready; Steven L McKnight; Andrew A Pieper
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-01       Impact factor: 11.205

6.  Global gene expression profiling of somatic motor neuron populations with different vulnerability identify molecules and pathways of degeneration and protection.

Authors:  Eva Hedlund; Martin Karlsson; Teresia Osborn; Wesley Ludwig; Ole Isacson
Journal:  Brain       Date:  2010-08       Impact factor: 13.501

7.  Relationship between mutant Cu/Zn superoxide dismutase 1 maturation and inclusion formation in cell models.

Authors:  Jacob I Ayers; Benjamin McMahon; Sabrina Gill; Herman L Lelie; Susan Fromholt; Hilda Brown; Joan Selverstone Valentine; Julian P Whitelegge; David R Borchelt
Journal:  J Neurochem       Date:  2016-11-25       Impact factor: 5.372

Review 8.  Immature copper-zinc superoxide dismutase and familial amyotrophic lateral sclerosis.

Authors:  Sai V Seetharaman; Mercedes Prudencio; Celeste Karch; Stephen P Holloway; David R Borchelt; P John Hart
Journal:  Exp Biol Med (Maywood)       Date:  2009-07-13

9.  Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients.

Authors:  Karin Forsberg; P Andreas Jonsson; Peter M Andersen; Daniel Bergemalm; Karin S Graffmo; Magnus Hultdin; Johan Jacobsson; Roland Rosquist; Stefan L Marklund; Thomas Brännström
Journal:  PLoS One       Date:  2010-07-14       Impact factor: 3.240

10.  TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis.

Authors:  Jemeen Sreedharan; Ian P Blair; Vineeta B Tripathi; Xun Hu; Caroline Vance; Boris Rogelj; Steven Ackerley; Jennifer C Durnall; Kelly L Williams; Emanuele Buratti; Francisco Baralle; Jacqueline de Belleroche; J Douglas Mitchell; P Nigel Leigh; Ammar Al-Chalabi; Christopher C Miller; Garth Nicholson; Christopher E Shaw
Journal:  Science       Date:  2008-02-28       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.